Drug Type Chemical drugs |
Synonyms IPR 1110 |
Target |
Mechanism uPA inhibitors(Urokinase plasminogen activator inhibitors), uPAR inhibitors(Urokinase plasminogen activator surface receptor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Dec 2020 | |
Asthma | Preclinical | DE | 26 Aug 2019 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | DE | 16 Aug 2019 |